Cyclic homopentapeptides 2. Synthetic modifications of viomycin

This paper describes synthetic modifications of the C-19 position of tuberactinomycin B (viomycin) and related analogs. The in vitro antibacterial activity of selected analogs against Pasteurella multocida, Escherichia coli and methicillin-resistant Staphylococcus aureus is also discussed. Although...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 7; no. 9; pp. 1145 - 1148
Main Authors Lyssikatos, J.P., Chang, S.-P., Clancy, J., Dirlam, J.P., Finegan, S.M., Girard, A.E., Hayashi, S.F., Larson, D.P., Lee, A.S., Linde, R.G., MacLelland, C.P., Petitpas, J.W., Seibel, S.B., Vu, C.B.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 06.05.1997
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This paper describes synthetic modifications of the C-19 position of tuberactinomycin B (viomycin) and related analogs. The in vitro antibacterial activity of selected analogs against Pasteurella multocida, Escherichia coli and methicillin-resistant Staphylococcus aureus is also discussed. Although C-19 arylation and thiolation did not improve antibacterial activity, C-19 benzyl carbamates, benzyl- and phenyl ureas were found to be more potent than the parent antibiotic. This paper describes synthetic modifications of the C-19 position of tuberatino-mycin B (viomycin) and related analogs. The in vitro antibacterial activity of selected analogs against Pasteurella multocida, Escherichia coli and methicillin-resistant Staphylococcus aureus is also discussed.
ISSN:0960-894X
1464-3405
DOI:10.1016/S0960-894X(97)00187-X